This achievement reaffirms Spirit’s ability to handle air cargo shipment with COVID-19 vaccines, other pharmaceuticals and medical equipment that require correct temperature-controlled handling and storage.
Performed by an IATA appointed independent, the audit, prior to receiving the second IATA CEIV Pharma certification at CPH, confirms and approves that Spirit’s management, and quality systems, processes, procedures and policies are in compliance with the demands for handling of these important shipments.
“We are very proud to receive the IATA CEIV Pharma certificate for the second time, as this means we, once again, have achieved one of the highest standards recognised by the pharmaceutical and the air cargo industries,” affirmed Hans-Henrik Spangenberg, CEO of SAS Ground Handling Denmark.
